Bio-Bridge Science, Inc. (OTCBB:BGES stock), a biotechnology company engaged
in the commercial development of vaccines for the prevention and
treatment of human infectious...
OAK BROOK, Ill.--(BUSINESS WIRE)--Bio-Bridge Science, Inc. (OTCBB: BGES) announced today that it has entered into a cooperative agreement with the Institute of Basic Medical Sciences at...
OAK-BROOK,-Ill.--(BUSINESS WIRE)--According to a joint report issued by UNAIDS and WHO, an estimated 39.5
million people globally are living with HIV and an estimated 4.3 million ...
OAK BROOK, Ill.--(BUSINESS WIRE)--Bio-Bridge Science, Inc.(OTCBB:BGES) a developer of vaccines with broad
preventative and therapeutic applications, is pleased to announce that
all...
OAK BROOK, Ill.--(BUSINESS WIRE)--Bio-Bridge Science, Inc. (OTCBB:BGES) a developer of vaccines with broad
preventative and therapeutic applications, is pleased to announce that
the...
OAK BROOK, Ill.--(BUSINESS WIRE)--July 7, 2006--Bio-Bridge Science, Inc. (OTCBB:BGES) a developer of vaccines with broad preventative and therapeutic applications, is pleased to announce that the...